Viking Therapeutics Stock Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily (IBD) provides information solely for informational and educational purposes and does not constitute an offer or recommendation to buy or sell securities.
- The data presented is sourced from what IBD believes are reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance shown is not indicative of future results, and authors or presenters may hold positions in the stocks they discuss.
- IBD disclaims any warranties about the advisability of investing in specific securities or strategies, and information is subject to change without notice.
- Real-time price data is provided by Nasdaq Last Sale, with ownership and estimate data from LSEG and FactSet, and all trademarks are owned by Investor’s Business Daily, LLC.
